SG Americas Securities LLC lifted its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 136.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 311,502 shares of the real estate investment trust’s stock after purchasing an additional 179,739 shares during the quarter. SG Americas Securities LLC’s holdings in Ventas were worth $25,475,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also modified their holdings of VTR. Vanguard Group Inc. lifted its position in Ventas by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares during the period. State Street Corp increased its holdings in Ventas by 2.5% in the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock valued at $2,309,234,000 after buying an additional 735,620 shares during the period. Geode Capital Management LLC raised its stake in shares of Ventas by 3.8% in the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock valued at $1,001,447,000 after buying an additional 475,633 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Ventas by 27.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock valued at $710,060,000 after buying an additional 2,000,341 shares in the last quarter. Finally, Capital World Investors bought a new position in shares of Ventas during the 4th quarter worth about $594,116,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.
Ventas Trading Up 1.6%
Shares of Ventas stock opened at $86.72 on Thursday. Ventas, Inc. has a 12-month low of $61.76 and a 12-month high of $91.06. The stock has a market capitalization of $42.16 billion, a P/E ratio of 157.67, a price-to-earnings-growth ratio of 1.83 and a beta of 0.71. The company has a 50-day simple moving average of $85.08 and a 200 day simple moving average of $82.69. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.
Ventas Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s payout ratio is presently 378.18%.
Insider Buying and Selling
In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Several brokerages have recently weighed in on VTR. KeyCorp lifted their target price on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. The Goldman Sachs Group restated a “buy” rating and set a $110.00 price target on shares of Ventas in a research note on Tuesday, May 19th. UBS Group lifted their price objective on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price objective on shares of Ventas in a research note on Monday, May 4th. Finally, Evercore restated an “outperform” rating and set a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $96.00.
View Our Latest Stock Analysis on VTR
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
